Compare · GH secretagogue
CJC-1295 vs Sermorelin
Both are gh secretagogue compounds. Here's how they line up on the evidence — graded the same way.
| CJC-1295 | Sermorelin | |
|---|---|---|
| Evidence | Preliminary human | Preliminary human |
| Class | GH secretagogue | GH secretagogue |
| Summary | A long-acting GHRH analog that raises GH and IGF-1 in short human trials, but has no clinical-outcome data, is not FDA-approved, and is banned in sport. | Sermorelin is a synthetic GHRH fragment that nudges the pituitary to release growth hormone; human data is old and thin, with no modern anti-aging RCTs. |
| Full profile → | Full profile → |
CJC-1295
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to make the body secrete more of its own growth hormone (GH). Short human studies confirm it raises GH and IGF-1, but no trial has shown it changes any health or performance outcome, and no version is FDA-approved.
Sermorelin
Sermorelin is one of the oldest peptides in the "growth hormone" category, and unlike most of its peers it once held FDA approval. That history is often used to imply more about its benefits than the evidence supports.